Stoke Therapeutics Cash Flow Statement (2018-2026) | STOK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-22.00M	-22.64M	-24.49M	-24.69M	-24.69M	-26.15M	-25.70M	-22.59M	-30.70M	-24.58M	-27.00M	-26.37M	-25.70M	-26.43M	-10.68M	112.88M	-23.48M	-38.35M	-57.82M	-50.00M
Depreciation and Depletion (Quarter)	0.25M	0.25M	0.26M	0.25M	0.30M	0.39M	0.61M	0.60M	0.61M	0.64M	0.62M	0.56M	0.55M	0.54M	0.55M	0.48M	0.45M	0.44M	0.41M	0.44M
Share-based Compensation (Quarter)	4.45M	4.61M	4.69M	4.97M	6.16M	5.93M	5.79M	5.89M	6.76M	6.55M	6.06M	5.41M	7.43M	7.49M	7.17M	6.75M	7.60M	8.04M	9.81M	8.75M
Gains from Sales and Divestitures (Quarter)															0.09M
Gains from Investment Securities (Quarter)	1.19M	1.25M		2.06M	0.36M	0.08M	3.46M	1.19M	0.28M	0.10M		1.10M	0.90M	0.73M	7.99M	1.96M	0.41M	0.81M	11.99M	1.34M
Asset Writedowns and Impairment (Quarter)																		0.70M
Non-cash Items (Quarter)			64.98M				20.60M				8.44M				20.42M				184.39M
Cash from Operations (Quarter)	-15.83M	-14.68M	-16.26M	32.49M	-19.93M	-22.06M	-22.37M	-21.36M	-21.80M	-17.26M	-20.65M	-24.57M	-17.48M	-21.61M	-23.19M	131.83M	-25.42M	-30.37M	-30.45M	-60.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)		0.05M	0.06M	0.23M	-0.19M	-0.10M	-0.15M	0.03M	-0.15M	-0.12M	-0.09M	-0.02M	-0.29M	-0.55M	-0.78M	-0.49M	0.53M	-0.61M	-0.55M	-0.36M
Depreciation & Amortization (CF) (Quarter)	0.25M	0.25M	0.26M	0.25M	0.30M	0.39M	0.61M	0.60M	0.61M	0.64M	0.62M	0.56M	0.55M	0.54M	0.55M	0.48M	0.45M	0.44M	0.41M	0.44M
Change in Working Capital
Change in Receivables (Quarter)															-0.30M	1.32M			-3.31M	-1.49M
Change in Accured Expenses (Quarter)	2.34M	2.45M	3.60M	-3.44M	1.06M	-1.35M	0.20M	0.35M	-4.43M	2.02M	-1.15M	-1.92M	3.58M	-0.75M	2.18M	4.74M	2.77M	4.88M	8.90M	-15.72M
Investing Activities
Capital Expenditures (Quarter)	0.52M	-0.69M	1.16M	0.84M	0.68M	-1.12M	3.56M	0.55M	0.46M	0.38M	0.23M	0.01M	-0.01M	0.16M	-0.10M	0.15M	-0.10M	0.39M	0.04M	0.33M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)				9.00M	53.37M	79.00M	18.03M	53.25M	24.31M	15.00M	15.00M	10.00M		20.00M	30.00M	32.80M	33.23M	33.15M	37.40M	60.90M
Cash from Investing Activities (Quarter)	-82.75M	-5.26M	11.80M	-135.78M	0.15M	67.26M	22.49M	53.09M	23.47M	14.62M	14.77M	9.99M	-88.28M	-30.00M	0.82M	13.63M	-148.48M	9.09M	-61.06M	50.69M
Financing Activities
Other financing activities (Quarter)		0.00M	-0.00M
Change in Capital Stock
Shares Issued (Quarter)		0.43M	0.17M	0.09M	0.33M	0.03M	0.12M	0.16M	0.05M	0.16M	0.19M	0.17M	0.85M	0.14M	0.57M	1.00M	0.55M	-0.56M	7.60M	0.47M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.16M	0.41M	0.17M	42.51M	3.42M	0.43M	0.04M	45.05M	0.05M	0.56M	7.34M	1.72M	120.65M	8.16M	0.57M	1.37M	0.55M	3.12M	92.34M	84.33M
Change in Cash (Quarter)	-98.43M	-19.54M	-4.29M	-60.78M	-16.36M	45.64M	0.16M	76.78M	1.72M	-2.08M	1.47M	-12.86M	14.89M	-43.46M	-21.81M	146.83M	-173.34M	-18.15M	0.83M	74.44M
Free Cash Flow (Quarter)	-16.35M	-14.00M	-17.42M	31.65M	-20.61M	-20.94M	-25.93M	-21.90M	-22.26M	-17.64M	-20.88M	-24.57M	-17.47M	-21.78M	-23.09M	131.68M	-25.32M	-30.75M	-30.50M	-60.92M
Net Cash Flow (Quarter)	-98.43M	-19.54M	-4.29M	-60.78M	-16.36M	45.64M	0.16M	76.78M	1.72M	-2.08M	1.47M	-12.86M	14.89M	-43.46M	-21.81M	146.83M	-173.34M	-18.15M	0.83M	74.44M

Research Tools

Developers

Stoke Therapeutics Cash Flow Statement (2018-2026) | STOK

Research Tools

Developers

Stoke Therapeutics Cash Flow Statement (2018-2026) | STOK

Create an account

Sign In

Reset Password